236 related articles for article (PubMed ID: 2663733)
1. Up-regulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) of induction of lymphokine (IL-2)-activated killer (LAK) cells by human blood monocytes.
Singh SM; Sone S; Inamura N; Ogura T
Int J Cancer; 1989 Jul; 44(1):170-6. PubMed ID: 2663733
[TBL] [Abstract][Full Text] [Related]
2. Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells.
Sone S; Inamura N; Singh SM; Okubo A; Yanagawa H; Nakanishi M; Ogura T
Jpn J Cancer Res; 1989 Jul; 80(7):662-9. PubMed ID: 2507489
[TBL] [Abstract][Full Text] [Related]
3. Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor.
Blanchard DK; Serbousek D; Djeu JY
Cancer Res; 1989 Sep; 49(18):5037-43. PubMed ID: 2670200
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of monocytes to lymphokine-activated killer cell lysis: effect of granulocyte-macrophage colony-stimulating factor and interleukin-3.
Djeu JY; Widen R; Blanchard DK
Blood; 1989 Apr; 73(5):1264-71. PubMed ID: 2649172
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A).
Masucci G; Ragnhammar P; Wersäll P; Mellstedt H
Cancer Immunol Immunother; 1990; 31(4):231-5. PubMed ID: 2199042
[TBL] [Abstract][Full Text] [Related]
6. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M
Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine-activated killer cell regulation of T-cell-mediated immunity to Candida albicans.
Wei S; Blanchard DK; McMillen S; Djeu JY
Infect Immun; 1992 Sep; 60(9):3586-95. PubMed ID: 1500166
[TBL] [Abstract][Full Text] [Related]
8. Coinduction of granulocyte-macrophage colony-stimulating factor release and lymphokine-activated killer cell susceptibility in monocytes by interleukin-2 via interleukin-2 receptor beta.
Epling-Burnette PK; Wei S; Blanchard DK; Spranzi E; Djeu JY
Blood; 1993 Jun; 81(11):3130-7. PubMed ID: 8499646
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of human lymphokine (IL-2)-activated killer (LAK) precursors and regulation of their LAK induction by blood monocytes.
Sone S; Inamura N; Nii A; Ogura T
Int J Cancer; 1988 Sep; 42(3):428-34. PubMed ID: 3262092
[TBL] [Abstract][Full Text] [Related]
10. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in responses of human blood monocytes to granulocyte-macrophage colony-stimulating factor.
Inamura N; Sone S; Okubo A; Singh SM; Ogura T
J Leukoc Biol; 1990 Jun; 47(6):528-34. PubMed ID: 2191064
[TBL] [Abstract][Full Text] [Related]
12. Suppression of human monocyte function against Candida albicans by autologous IL-2-induced lymphokine-activated killer cells.
Wei S; Serbousek D; McMillen S; Blanchard DK; Djeu JY
J Immunol; 1991 Jan; 146(1):337-42. PubMed ID: 1898605
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte/macrophage-colony-stimulating factor augments lymphokine-activated killer activity from lymphocytes via macrophages in lung cancer patients.
Takahashi K; Saito S; Kamamura Y; Katakawa M; Monden Y
Cancer Immunol Immunother; 2000 Dec; 49(10):537-43. PubMed ID: 11129324
[TBL] [Abstract][Full Text] [Related]
14. Effect of granulocyte-macrophage colony-stimulating factor on lymphokine-activated killer cell induction.
Stewart-Akers AM; Cairns JS; Tweardy DJ; McCarthy SA
Blood; 1993 May; 81(10):2671-8. PubMed ID: 8490177
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma-induced alterations of monocyte susceptibility to lysis by autologous lymphokine-activated killer (LAK) cells.
Djeu JY; Blanchard DK
Int J Cancer; 1988 Sep; 42(3):449-54. PubMed ID: 3138195
[TBL] [Abstract][Full Text] [Related]
16. Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state.
Nii A; Sone S; Utsugi T; Yanagawa H; Ogura T
Int J Cancer; 1988 Jan; 41(1):33-40. PubMed ID: 2826345
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor (GM-CSF) counteracts the inhibiting effect of monocytes on natural killer (NK) cells.
van den Bosch G; Preijers F; Vreugdenhil A; Hendriks J; Maas F; De Witte T
Clin Exp Immunol; 1995 Sep; 101(3):515-20. PubMed ID: 7664499
[TBL] [Abstract][Full Text] [Related]
18. The effects of recombinant human granulocyte-macrophage colony-stimulating factor on the induction of lymphokine-activated killer cells in vitro.
Okamura S; Tanaka T; Yamaga S; Omori F; Niho Y
Int J Immunopharmacol; 1991; 13(5):587-93. PubMed ID: 1783473
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity.
Sone S; Utsugi T; Nii A; Ogura T
J Natl Cancer Inst; 1988 May; 80(6):425-31. PubMed ID: 3130488
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.
Wang M; Friedman H; Djeu JY
J Immunol; 1989 Jul; 143(2):671-7. PubMed ID: 2661688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
